Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Biosimilars lower costs but don't significantly improve access.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Mutations in the LIPH gene cause woolly hair in a child.

Suppressing ODC activity reduces tumor growth in hair follicles.

PCOS is linked to low-grade chronic inflammation.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Ocrelizumab may cause pancreatitis in some patients.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

A new dissolving microneedle system effectively delivers minoxidil for hair regrowth with minimal side effects.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Oral minipulse therapy effectively treated bullous lichen planus in a 35-year-old woman.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

AtZP1 protein stops root hair growth in plants by blocking certain genes.